...
首页> 外文期刊>Critical care : >Central venous O2 saturation and venous-to-arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery
【24h】

Central venous O2 saturation and venous-to-arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery

机译:中心静脉血O 2 饱和度和静脉与动脉之间的CO 2 差异作为高风险手术中目标导向治疗的补充工具

获取原文

摘要

IntroductionCentral venous oxygen saturation (ScvO2) is a useful therapeutic target in septic shock and high-risk surgery. We tested the hypothesis that central venous-to-arterial carbon dioxide difference (P(cv-a)CO2), a global index of tissue perfusion, could be used as a complementary tool to ScvO2 for goal-directed fluid therapy (GDT) to identify persistent low flow after optimization of preload has been achieved by fluid loading during high-risk surgery.MethodsThis is a secondary analysis of results obtained in a study involving 70 adult patients (ASA I to III), undergoing major abdominal surgery, and treated with an individualized goal-directed fluid replacement therapy. All patients were managed to maintain a respiratory variation in peak aortic flow velocity below 13%. Cardiac index (CI), oxygen delivery index (DO2i), ScvO2, P(cv-a)CO2 and postoperative complications were recorded blindly for all patients.ResultsA total of 34% of patients developed postoperative complications. At baseline, there was no difference in demographic or haemodynamic variables between patients who developed complications and those who did not. In patients with complications, during surgery, both mean ScvO2 (78 ± 4 versus 81 ± 4%, P = 0.017) and minimal ScvO2 (minScvO2) (67 ± 6 versus 72 ± 6%, P = 0.0017) were lower than in patients without complications, despite perfusion of similar volumes of fluids and comparable CI and DO2i values. The optimal ScvO2 cut-off value was 70.6% and minScvO2 < 70% was independently associated with the development of postoperative complications (OR = 4.2 (95% CI: 1.1 to 14.4), P = 0.025). P(cv-a)CO2 was larger in patients with complications (7.8 ± 2 versus 5.6 ± 2 mmHg, P < 10-6). In patients with complications and ScvO2 ≥71%, P(cv-a)CO2 was also significantly larger (7.7 ± 2 versus 5.5 ± 2 mmHg, P < 10-6) than in patients without complications. The area under the receiver operating characteristic (ROC) curve was 0.785 (95% CI: 0.74 to 0.83) for discrimination of patients with ScvO2 ≥71% who did and did not develop complications, with 5 mmHg as the most predictive threshold value.ConclusionsScvO2 reflects important changes in O2 delivery in relation to O2 needs during the perioperative period. A P(cv-a)CO2 < 5 mmHg might serve as a complementary target to ScvO2 during GDT to identify persistent inadequacy of the circulatory response in face of metabolic requirements when an ScvO2 ≥71% is achieved.Trial registrationClinicaltrials.gov Identifier: NCT00852449.
机译:简介中央静脉血氧饱和度(ScvO2)是脓毒性休克和高风险手术的有用治疗靶标。我们测试了以下假设:中心静脉-动脉二氧化碳差异(P(cv-a)CO2)(组织灌注的全球指标)可以用作ScvO2的补充工具,用于目标定向流体治疗(GDT)方法这是对一项涉及70名成年患者(ASA I至III),接受了大腹部手术并接受过治疗的研究的结果的二级分析个性化的针对目标的补液疗法。所有患者均设法使主动脉流速峰值的呼吸变化保持在13%以下。所有患者均盲目记录心脏指数(CI),氧气输送指数(DO2i),ScvO2,P(cv-a)CO2和术后并发症。结果,共有34%的患者出现了术后并发症。在基线时,发生并发症的患者与未发生并发症的患者之间的人口统计学或血液动力学变量没有差异。对于有并发症的患者,在手术期间,平均ScvO2(78±4比81±4%,P = 0.017)和最小ScvO2(minScvO2)(67±6对72±6%,P = 0.0017)均低于患者尽管灌注了相似体积的液体,并且具有相似的CI和DO2i值,但无并发症。最佳ScvO2截止值为70.6%,minScvO2 <70%与术后并发症的发生独立相关(OR = 4.2(95%CI:1.1至14.4),P = 0.025)。合并症患者的P(cv-a)CO2较大(7.8±2 vs 5.6±2 mmHg,P <10-6)。在并发症和ScvO2≥71%的患者中,P(cv-a)CO2也显着大于无并发症的患者(7.7±2 vs 5.5±2 mmHg,P <10-6)。接受者操作特征(ROC)曲线下的面积为0.785(95%CI:0.74至0.83),用于区分是否发生并发症的ScvO2≥71%的患者,最容易预测的阈值为5 mmHg。反映了围手术期氧气输送量相对于氧气需求的重要变化。在GDT期间,P(cv-a)CO2 <5 mmHg可以作为ScvO2的补充目标,以在达到ScvO2≥71%时面对代谢需求而确定循环反应的持续不足。试验注册Clinicaltrials.gov标识符:NCT00852449。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号